Relative mRNA expression level (/J3T-1)

Slides:



Advertisements
Similar presentations
Control VEGF 165 b bevacizumab PC3 cells Saline VEGF 165 b A. B. C.D SalineVEGF 165 b Bevacizumab Vessels/mm -2 ** * Supplementary.
Advertisements

Cell Physiol Biochem 2017;42:2582– DOI: /
Fig. 1 Increased MIR155HG expression correlates with glioma grade and mesenchymal transition and confers a poor prognosis in GBM patients. (A) The level.
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a Cell Physiol Biochem.
Saikosaponin-D Enhances Radiosensitivity of Hepatoma Cells under Hypoxic Conditions by Inhibiting Hypoxia-Inducible Factor-1α Cell Physiol Biochem 2014;33:37-51.
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate- Specific Antigen-Relapse Following Radical Prostatectomy  Johannes Stein,
Figure 1 Body weight of control and BPA-treated mothers after delivery
Fig. 4. TR3-dependent induction of ATF3 by DIM-C-pPhOCH 3 in human pancreatic cancer cells. ( A ) Induction of ATF3 by DIM-C-pPhOCH 3
Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma Cell Physiol Biochem 2017;44:99–109.
Volume 15, Issue 6, Pages (June 2009)
Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma  Jia Wang, Tong Yang, Gaofeng Xu, Hao Liu, Chunying.
Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis 
Nuclear Factor of Activated T Cells 5 Deficiency Increases the Severity of Neuronal Cell Death in Ischemic Injury Neurosignals 2012;20:237–251 - DOI: /
DNMT3B Overexpression by Deregulation of FOXO3a-Mediated Transcription Repression and MDM2 Overexpression in Lung Cancer  Yi-Chieh Yang, MS, Yen-An Tang,
Volume 20, Issue 4, Pages e4 (April 2017)
Jasmine George, Minakshi Nihal, Chandra K
Expression of KRAS in the endometrium of early pregnant mice and its effect during embryo implantation  Xia Long, Min Zhang, Xuemei Chen, Junlin He, Yubin.
Volume 85, Issue 2, Pages (January 2014)
The Chemopreventive Effect of Tanacetum Polycephalum Against LA7-Induced Breast Cancer in Rats and the Apoptotic Effect of a Cytotoxic Sesquiterpene.
Volume 137, Issue 2, Pages e2 (August 2009)
Intermittent cyclic mechanical tension promotes endplate cartilage degeneration via canonical Wnt signaling pathway and E-cadherin/β-catenin complex cross-talk 
Genetic evidence for a tumor suppressor role of HIF-2α
Verena N. Lorenz, Michael P. Schön, Cornelia S. Seitz 
Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric Cancer  Ryo Yuge, Yasuhiko Kitadai,
Cell Physiol Biochem 2016;39: DOI: /
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Molecular Therapy - Nucleic Acids
Volume 8, Issue 6, Pages (December 2005)
CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis
Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes  Kiyoko Setoguchi, Lin.
Glyoxalase I Is Differentially Expressed in Cutaneous Neoplasms and Contributes to the Progression of Squamous Cell Carcinoma  Xiao-Yan Zou, Dong Ding,
Volume 6, Issue 5, Pages (March 2014)
Molecular Therapy - Methods & Clinical Development
Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer  Sang Hoon Rhee, Eunok Im, Charalabos.
CaMKII inhibition in human primary and pluripotent stem cell-derived chondrocytes modulates effects of TGFβ and BMP through SMAD signaling  B. Saitta,
Volume 23, Issue 5, Pages (May 2015)
Uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non- Small-Cell Lung Cancer  Jun Zhou, Chenghai Wang, Weijuan Gong, Yandan.
Volume 152, Issue 1, Pages (January 2019)
Proliferative and Survival Effects of PUMA Promote Angiogenesis
Bacterial Carriers for Glioblastoma Therapy
Volume 25, Issue 3, Pages (March 2017)
Volume 134, Issue 2, Pages e3 (February 2008)
Regulation of Fibulin-2 Gene Expression by Integrin α3β1 Contributes to the Invasive Phenotype of Transformed Keratinocytes  Dara S. Missan, Sridar V.
Fig. 7. KIF11 informs patient prognosis, and targeting improves survival in a preclinical model. KIF11 informs patient prognosis, and targeting improves.
Integrin Alpha 6 Regulates Glioblastoma Stem Cells
NADPH Oxidase 1 Overexpression Enhances Invasion via Matrix Metalloproteinase-2 and Epithelial–Mesenchymal Transition in Melanoma Cells  Feng Liu, Angela.
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK
Yabin Cheng, Guangdi Chen, Magdalena Martinka, Vincent Ho, Gang Li 
Myeloma cell–derived Runx2 promotes myeloma progression in bone
Volume 21, Issue 11, Pages (November 2014)
GRM7 Regulates Embryonic Neurogenesis via CREB and YAP
Volume 17, Issue 2, Pages (February 2009)
Volume 25, Issue 4, Pages (April 2017)
Jasmine George, Minakshi Nihal, Chandra K
Volume 26, Issue 8, Pages (August 2018)
Volume 15, Issue 6, Pages (June 2009)
Long Noncoding RNA BC as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3  Jiaxin Lin, Xin Tan,
Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma by Ilyas Sahin, Yawara Kawano, Romanos.
LIMD1 hypoxic induction occurs via HIF‐1 and facilitates formation of a hypoxic HIF‐1 degradation complex LIMD1 hypoxic induction occurs via HIF‐1 and.
Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia  Raquel Vinhas, Alexandra R.
EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis  Szu-Wei Lee, Yijuan Zhang, Michael Jung, Nathalia Cruz, Basheer.
Volume 33, Issue 1, Pages (April 2015)
Fig. 1. DEL-1 is expressed by human and mouse osteoclasts.
Effects of HDAC2 inactivation on the invasive potential of human gastric cancer cells. Effects of HDAC2 inactivation on the invasive potential of human.
The effects of HDAC2 knockdown on cell-cycle proteins.
Rumwald Leo G Lecaros, Leaf Huang, Tsai-Chia Lee, Yih-Chih Hsu 
Fig. 5 C9orf72 knockdown disrupts autophagy induction.
Fig. 2 IDH3α regulates GBM progression in vivo.
Presentation transcript:

Relative mRNA expression level (/J3T-1) B Relative mRNA expression level (/J3T-1) J3T-1 J3T-2 * J3T2 J3T1 Supplementary Fig. 1 Microarray analysis of J3T-2 compared with J3T-1 identified novel invasion-related gene, FGF13. (A) Microarray analysis showed 791 differentially expressed genes that presenting fold changes > 2.0 between J3T-1 and J3T-2, which consisted of 418 genes overexpressed in J3T-1 and 373 genes overexpressed in J3T-2. (B) FGF13 mRNA expression was markedly up-regulated in J3T-2 than J3T-1 (n=6). Statistical significance was calculated by the Student’s T-test. *p < 0.01.

A CD31 FGF13 B Iba-1 FGF13 Supplementary Fig. 2 Microenvironmental cells like endothelial cells or macrophages did not express FGF13. Serial section analysis in immunohistochemistry revealed that tumor cells expressed FGF13 (arrow head), however, endothelial cells (arrow, A) or macrophages (arrow, B) did not express FGF13. Scale bar, 50 μm

Supplementary Fig. 3 FGF13 expression in glioma subtypes.

A B C D Supplementary Fig. 4 siRNA NC #1 #2 J3T-2 U87ΔEGFR A172 * J3T-2 p=0.08 * * * Relative ratio of invasion cells (/NC) U87ΔEGFR NC #1 #2 NC #1 #2 NC #1 #2 siRNA siRNA siRNA A172 C D A172 Gli36Δ5 * * Relative ratio of migration cells (/NC) Relative FGF13 mRNA expression level (/NHA) NC #1 #2 NC #1 #2 A172 NHA Gli36Δ5 siRNA siRNA Supplementary Fig. 4 FGF13 was involved in glioma invasion in vitro. (A, B) Knockdown of FGF13 by siRNA decreased the invasion activity of J3T-2 and U87ΔEGFR cells (n=10). In contrast, silencing of FGF13 did not affect the invasion activity of A172 (n=10). (C) A172 and Gli36Δ5 cell lines expressed very low levels of FGF13 (n=6) compared with that of normal human astrocyte (NHA). (D) Silencing of FGF13 did not affect the migration activity of A172 and Gli36Δ5 cells. Data are shown as the mean ± SEM. Statistical significance was calculated by ANOVA with the Dunnett’s post hoc test. *p < 0.05. NC = negative control siRNA.

A siRNA siRNA siRNA siRNA NC #1 #2 NC #1 #2 NC #1 #2 NC #1 #2 TUNEL DAPI MERGE J3T-2 U87ΔEGFR U251 LNZ308 B J3T-2 U87ΔEGFR U251 LNZ308 p=0.82 p=0.86 p=0.70 p=0.62 % TUNEL-positive cells Bar 50um NC #1 #2 NC #1 #2 NC #1 #2 NC #1 #2 siRNA siRNA siRNA siRNA Supplementary Fig. 5 Silencing of FGF13 did not induce apoptosis of glioma cell lines in vitro. (A) Representative pictures from five experiments are shown. TUNEL-positive cells, green; DAPI = 4, 6-diamidino-2-phenylindole, blue. Bar = 50 μm. (B) Silencing of FGF13 did not induce apoptosis of glioma cell lines in vitro. (n=5) Statistical significance was calculated by ANOVA with Dunnett’s post hoc test.

A C D E B F Supplementary Fig. 6 Ipsilateral Contralateral * * * * * * MIB-1 index (%) scramble #1 #2 expression level (/scramble)z Relative FGF13 mRNA Invading cells (/scramble) Invading cells (/scramble) E shRNA scramble #1 #2 scramble #1 #2 scramble #1 #2 Vessel density (/HPF) shRNA shRNA shRNA B scramble #1 #2 Ipsilateral Contralateral F shRNA scramble shRNA FGF13 shRNA#1 FGF13 shRNA#2 ** ** 100 80 Survival(%) 60 40 20 10 20 30 40 50 60 70 Supplementary Fig. 6 FGF13 was involved in glioma invasion in MGG23 and reduction of FGF13 improved overall survival. (A) The relative expression level of FGF13 mRNA was decreased by shRNA in MGG23 cells (n = 3). (B, C) Knockdown of FGF13 in MGG23 impaired glioma invasion as well as MGG8 (n=3). Scale bars, 50 µm. (D, E) Silencing of FGF13 had no effect on cell proliferation and angiogenesis (n=3). (D) Kaplan-Meier survival curves of intracranial xenografts with MGG23 cells expressing FGF13 shRNA#1, FGF13 shRNA#2, or scramble shRNA. The survival time of MGG23 expressing either FGF13 shRNA#1 or FGF13 shRNA#2 (median survival = 68 or 65.5 days, respectively) were significantly longer than that of scramble shRNA (58days) (n=8). *p < 0.01, **p < 0.05 Days after implantation (days)

The FGF13 expression was negatively regulated by hypoxia. * * * * Relative CA9 mRNA expression level (/DMSO) Relative FGF13B expression (/Normoxia) Relative CA9 mRNA expression level (/Normoxia) Relative FGF13B expression (/DMSO) Normoxia Hypoxia DMSO DFOM Normoxia Hypoxia DMSO DFOM C D * * * * Relative CA9 mRNA expression level (/Normoxia) Relative CA9 mRNA expression level (/DMSO) Relative FGF13B expression (/Normoxia) Relative FGF13B expression (/DMSO) Please note that the figure legends should be in a separate file. Normoxia Hypoxia DMSO DFOM Normoxia Hypoxia DMSO DFOM Supplementary Fig. 7 The FGF13 expression was negatively regulated by hypoxia. (A, C) The relative expression of CA9 mRNA, which is a marker of hypoxic condition, was significantly up-regulated by 1% O2 (hypoxia) or deferoxamine mesylate (DFMO) in both U87ΔEGFR (A) and U251 (C) (n=3). (B, D) The relative expression of FGF13B protein was significantly decreased by 1% o2 (hypoxia) or deferoxamine mesylate (DFMO) in both U87ΔEGFR (B) and U251 (D) (n=4). Data are shown as the mean ± SEM. Statistical significance was calculated by the Student’s T-test. *p < 0.05.

Silencing of FGF13 decreased bevacizumab-induced invasion. * A B C * D * * * * Relative ratio of invasion cells (/control) Relative FGF13B expression control Pre-bev Bev + NC Bev + #1 Bev + #2 control Bev + NC Bev + #1 Bev + #2 Post-bev Pre-bev Post-bev siRNA siRNA E Newly-diagnosed (Pre-bev) F Invasion edge Tumor Core Post-bev G Supplementary Fig. 8 Silencing of FGF13 decreased bevacizumab-induced invasion. (A, B) Western blotting of U87ΔEGFR (A) and U251 (B) showed that the expression level of FGF13B did not alter after bevacizumab treatment (n=4). Statistical significance was calculated by the Student’s T-test. (C, D) Double chamber assays showed that bevacizumab induced glioma invasion, but silencing of FGF13 inhibited the invasion of U87ΔEGFR (C) and U251 (D) (n=3). Statistical significance was calculated by Tukey’s post hoc test. NC = negative control siRNA. (E) Immunohistochemical staining of a human glioma specimen (case 25) showed FGF13 was expressed after bevacizumab treatment. (F, G) Immunohistochemical staining of U87ΔEGFR cells transfected with scramble shRNA treated with bevacizumab showed bevacizumab-induced invasion (F). In contrast, silencing of FGF13 decreased the invasiveness (G). The representative results are shown. Data are shown as the mean ± SEM. *p < 0.05.

Fig. 1E Fig. 2B FGF13 FGF13 25kD 25kD Actin Actin Fig. 5C Fig. 5B Acetylated-tubulin FGF13 FGF13 75kD 25kD U87ΔEGFR Tyrosinated-tubulin Actin U251 Actin Fig. 6A FGF13 25kD Actin Supplementary Fig. 9 Full scans of the immunoblots shown in the figure. Boxes indicated parts used in the figure and numbers indicated molecular weights.